Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 661 across all filing types
Latest filing 2025-12-25 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
北京市嘉源律师事务所关于深圳惠泰医疗器械股份有限公司2025年第四次临时股东会的法律意见书
Regulatory Filings Classification · 21% confidence The document is a legal opinion letter issued by counsel regarding the convening, procedures, attendance qualifications, and vote results of an extraordinary shareholders’ meeting. It is not the minutes of the meeting itself, nor is it a proxy solicitation or an earnings announcement. Rather, it is a compliance/legal filing appended for regulatory purposes. It does not fit a specific detailed category like DVA (which is typically the company’s formal vote results announcement), but rather is a general regulatory/legal compliance document. Therefore, under the fallback rules, it should be classified as a Regulatory Filing (RNS).
2025-12-25 Chinese
2025年第四次临时股东会会议资料
AGM Information Classification · 95% confidence The document is titled as meeting materials for the "2025 Fourth Extraordinary General Meeting of Shareholders" of Shenzhen Huitai Medical Device Co., Ltd. It contains detailed agenda, meeting instructions, and multiple proposals related to the 2026 expected daily related-party transactions, including detailed financial figures and descriptions of related parties and their transactions. The content is focused on shareholder meeting materials, including proposals to be voted on, meeting procedures, and legal compliance notes. There is no indication that this is a full annual report, audit report, earnings release, or other financial report. Instead, it is clearly a set of materials prepared for a specific shareholders' meeting, which aligns with the definition of AGM Information (AGM-R). The document length is substantial (15,000 characters), and it contains the actual meeting agenda and proposals, not just an announcement or notice. Therefore, the correct classification is AGM Information (AGM-R).
2025-12-16 Chinese
关于回购股份事项的前十名股东及前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement from Shenzhen Huitai Medical Equipment Co., Ltd. regarding the share repurchase (buyback) plan and the shareholding status of the top ten shareholders and top ten unrestricted shareholders as of a specific date. It references the board meeting approving the share repurchase plan and provides detailed shareholding data. The content focuses on share repurchase and shareholder holdings, which aligns with a report on the company's transactions in its own shares. The document length is short (1665 characters), but it contains substantive data about shareholdings related to the repurchase, not just a notice of report publication. Therefore, it fits best under the category of Transaction in Own Shares (POS).
2025-12-15 Chinese
关于公司2021年限制性股票激励计划首次授予及预留部分授予B类限制性股票第三个归属期第二次归属结果暨股份上市的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the registration and listing of shares related to the company's 2021 restricted stock incentive plan. It details the number of shares granted, the approval process, the registration completion, and the impact on share capital and earnings per share. It includes references to meetings, approvals, and regulatory compliance but does not contain comprehensive financial statements or detailed financial performance data. The document is primarily an official announcement about share issuance and listing related to stock incentives, not a full financial report or earnings release. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length is sufficient and contains detailed information about share issuance and capital changes, confirming this classification with high confidence.
2025-11-26 Chinese
北京市嘉源律师事务所关于深圳惠泰医疗器械股份有限公司2025年第三次临时股东会的法律意见书
Regulatory Filings Classification · 90% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendees, and voting results of the company’s 2025 third extraordinary shareholders’ meeting. It does not present financial statements, audit results, or serve as an investor presentation. Instead, it is a lawyer’s certification of procedural compliance under corporate and securities laws. Under the CERTIFICATION RULE, such legal opinion and attestation letters are classified as a general regulatory filing rather than as AGM materials, proxy statements, or financial reports. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-11-21 Chinese
关于董事会完成换届选举及聘任高级管理人员、证券事务代表的公告
Board/Management Information Classification · 100% confidence The document is an official announcement from Shenzhen Huitai Medical Devices Co., Ltd. regarding the completion of the board of directors' re-election and the appointment of senior management personnel and securities affairs representatives. It details the election of new board members, committee members, and senior executives, including their resumes and qualifications. The document is dated November 22, 2025, and includes specific information about the board structure and management changes. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of announcements related to changes in the company's board and senior management. Therefore, the document is best classified as Board/Management Information (MANG).
2025-11-21 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.